Annals of internal medicine

Annals of internal medicine
Audio Summaries

Every issue of Annals of internal medicine moves the field forward, but reading every paper cover-to-cover isn't realistic. OSLR turns each article into a 3-minute audio summary so you can stay current while you commute, round, or work out.

89 audio summariesNLM Catalog

Specialties

Annals of internal medicine covers research in these specialties.

Recent summaries

The latest articles summarized from Annals of internal medicine.

Acupoint Thread Embedding for Weight Loss in Women With Overweight or Obesity : A Randomized Controlled Trial.

Nov 16, 2026

This randomized, sham-controlled trial asked whether acupoint thread embedding (ATE), a traditional Chinese medicine procedure, promotes weight loss in 132 women aged 18 to 45 with overweight or obesity. Compared with sham ATE, ATE produced modest but sustained reductions in BMI (-0.7 kg/m² at 12 weeks, -1.1 kg/m² at 24 weeks) and body weight, along with greater decreases in waist and hip circumference and body fat percentage, with mild adverse events in both groups. Limitations include a single center, a homogeneous study population, unmasked acupuncturists, and short-term follow-up.

Doxycycline and Risk for Pregnancy Loss : A Multi-database, Multi-indication Cohort Study.

Nov 9, 2026

This retrospective cohort study examined whether first-trimester oral doxycycline use is linked to pregnancy loss, using commercial (MarketScan) and Medicaid claims data for pregnant women with respiratory infections or acne. Compared with amoxicillin or macrolides for respiratory infections, doxycycline was associated with a roughly 36–54% higher relative risk of pregnancy loss in both databases, while the comparison with topical clindamycin for acne was significant only in MarketScan. Given possible residual confounding and misclassification, and because congenital malformations were not assessed, the findings suggest clinicians should weigh doxycycline's benefits against this potential risk in reproductive-aged women.

Preconception Care.

Nov 9, 2026

This review examines best practices in preconception medical care for cisgender women who want to become pregnant, with the aim of improving fertility, perinatal well-being, and pregnancy outcomes. Because nearly half of U.S. pregnancies are unintended or mistimed, the authors argue that internal medicine physicians are well positioned to provide proactive reproductive counseling and optimize patients' health before conception.

In atopic dermatitis, H1 antihistamines do not provide a clinically important reduction in itch or disease severity.

Nov 2, 2026

Based on the title, this Annals of Internal Medicine article appears to ask whether H1 antihistamines meaningfully reduce itch or disease severity in atopic dermatitis. The authors conclude that they do not produce a clinically important benefit on either outcome. The abstract provided contains only formatting placeholders, so this summary relies on the title alone and the methods and effect sizes should be checked in the full text.

In elective cardiac surgery, perioperative dapagliflozin reduced acute kidney injury vs. placebo at 7 d.

Nov 2, 2026

This study asks whether perioperative dapagliflozin, an SGLT2 inhibitor, can prevent acute kidney injury (AKI) in patients undergoing elective cardiac surgery. The title reports that dapagliflozin reduced AKI compared with placebo at 7 days. The abstract provided contains no methods or effect sizes, so the sample size, AKI definition, and magnitude of benefit cannot be confirmed from this text.

Decompression With or Without Fusion Across Subgroups With Degenerative Lumbar Spondylolisthesis : A Target Trial Emulation.

Nov 2, 2026

This target trial emulation used Norwegian registry data (with a nested randomized trial) to compare decompression with fusion versus decompression alone for lumbar degenerative spondylolisthesis across patient subgroups. At 12 months, adding fusion did not meaningfully improve Oswestry Disability Index scores (mean difference 2.2 points, 95% CI -1.6 to 6.1) or change reoperation risk, and subgroup effects were generally similar, though fusion was associated with worse ODI in men with BMI ≥30 kg/m² in exploratory analyses. The authors conclude that fusion did not produce differential benefit across prespecified subgroups, though residual confounding remains a limitation.

In T2D, combined SGLT2i + GLP-1 RA vs. either alone does not reduce MACE or renal outcomes.

Nov 2, 2026

This Annals of Internal Medicine article appears to ask whether adding a GLP-1 receptor agonist to an SGLT2 inhibitor, compared with either drug alone, reduces major adverse cardiovascular events (MACE) or kidney outcomes in adults with type 2 diabetes. The authors' conclusion, as stated in the title, is that the combination offers no such benefit. The abstract provided is only a placeholder, so these findings are drawn from the title and not from the study's methods or data.

Use of GLP-1 RAs before or during pregnancy was not linked to maternal pregnancy complications.

Nov 2, 2026

This commentary-style item, published in *Annals of Internal Medicine*, appears to ask whether using GLP-1 receptor agonists (a class of diabetes and weight-loss drugs) before or during pregnancy is associated with maternal pregnancy complications. Its title suggests the answer was no, that such use was not linked to these complications. The abstract provided is only a placeholder, so the study design, sample, and specific outcomes could not be verified.

After successful catheter ablation in AF, discontinuing vs. continuing OAC reduces bleeding without increasing thromboembolic events.

Nov 2, 2026

This appears to be a commentary by Gregory Lip in *Annals of Internal Medicine*, but the abstract provided contains only placeholder text, so the details can't be verified. Based on the title, the question is whether patients can safely stop oral anticoagulation (OAC) after successful catheter ablation for atrial fibrillation, and the authors appear to conclude that stopping OAC reduces bleeding without increasing thromboembolic events. For accurate findings, methods, and sample sizes, please consult the full text.

After 12 mo of DAPT following PCI in multivessel CAD, extended DAPT vs. aspirin alone reduced MACCE without increasing bleeding.

Nov 2, 2026

**Note:** The abstract provided contains only subject-category tags, so this summary is based on the title alone and may not reflect the study's full design or results. This Annals of Internal Medicine commentary by Manoj Kesarwani appears to address whether continuing dual antiplatelet therapy (DAPT) beyond 12 months after percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease, compared with aspirin alone, reduces major adverse cardiac and cerebrovascular events (MACCE). The title reports that extended DAPT lowered MACCE without a significant increase in bleeding. Because the article type and full text were not available, the study population, sample size, and effect sizes could not be confirmed.

Listen to Annals of internal medicine

14-day free trial. Every new article, summarized in ~3 minutes.